Patients with heart failure were more likely to be prescribed ACE inhibitors (32.8% versus 24.5% for all patients) and diuretics (23.4% versus 15.7%), and less likely to be prescribed beta-blockers (12.5% versus 29.4%) (table 4). This evidence concerns the gene ACE and heart failure.